Publikationsdatum:
2012-10-11
Beschreibung:
Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML Leukemia 26, 2297 (October 2012). doi:10.1038/leu.2012.152 Authors: S Ettou, E Audureau, C Humbrecht, B Benet, H Jammes, T Clozel, V Bardet, C Lacombe, F Dreyfus, P Mayeux, E Solary & M Fontenay
Print ISSN:
0887-6924
Digitale ISSN:
1476-5551
Thema:
Medizin
Permalink